| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F |
| P698 | PubMed publication ID | 10211873 |
| P433 | issue | 4 | |
| P304 | page(s) | 599-608 | |
| P577 | publication date | 1999-04-01 | |
| P1433 | published in | Arthritis and Rheumatism | Q23929027 |
| P1476 | title | The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes | |
| P478 | volume | 42 |
| Q34654431 | 16/6-idiotype expressing antibodies induce brain inflammation and cognitive impairment in mice: the mosaic of central nervous system involvement in lupus |
| Q37131283 | 2013 update: Hopkins lupus cohort |
| Q35861014 | 25-Hydroxyvitamin D3 Deficiency Independently Predicts Cognitive Impairment in Patients with Systemic Lupus Erythematosus |
| Q41079086 | A 50-year-old with rapid neuropsychiatric deterioration and choreiform movements |
| Q37637787 | A Case of "Refractory" Neuropsychiatric Lupus Responsive to Anticoagulation |
| Q36006471 | A Case of Systemic Lupus Erythematosus Presenting as Guillain-Barré Syndrome |
| Q92326139 | A Challenging Diagnosis of Systemic Lupus Erythematosus with Status Epilepticus |
| Q60305455 | A Conscious Resting State fMRI Study in SLE Patients Without Major Neuropsychiatric Manifestations |
| Q52723423 | A Distinct T Follicular Helper Cell Subset Infiltrates the Brain in Murine Neuropsychiatric Lupus. |
| Q26774584 | A Systematic Review of Peripheral and Central Nervous System Involvement of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Primary Sjögren's Syndrome, and Associated Immunological Profiles |
| Q32178466 | A case of neuropsychiatric lupus Erythematosus characterized by the Owl's eye sign: a case report |
| Q33393399 | A case of spontaneous hemoperitoneum presenting as the initial manifestation of systemic lupus erythematosus |
| Q48675140 | A case of systemic lupus erythematosus with extensive brain stem involvement |
| Q90446471 | A challenging case of neuropsychiatric systematic lupus erythematosus with recurrent antiphospholipid- related stroke: A case report and literature review |
| Q48801770 | A clinically isolated syndrome: a challenging entity: multiple sclerosis or collagen tissue disorders: clues for differentiation |
| Q34405264 | A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammation |
| Q46650286 | A loss of sensation. |
| Q35760387 | A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus |
| Q37392464 | A neurometabolite study of chronic daily headache in patients with systemic lupus erythematosus using magnetic resonance spectroscopy: comparison with fibromyalgia patients and healthy controls |
| Q34114987 | A proposed framework to standardize the neurocognitive assessment of patients with pediatric systemic lupus erythematosus |
| Q40044248 | A rare case of meningoencephalitis by Listeria monocytogenes in systemic lupus erythematosus: case report and review |
| Q33163321 | Abnormalities of frontal-parietal resting-state functional connectivity are related to disease activity in patients with systemic lupus erythematosus. |
| Q37548266 | Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study |
| Q80625606 | Acute psychosis in systemic lupus erythematosus |
| Q51730570 | Acute psycosis in systemic lupus erythematosus. |
| Q26799922 | Advanced and Conventional Magnetic Resonance Imaging in Neuropsychiatric Lupus |
| Q40299868 | Age-related differences in the clinical characteristics of systemic lupus erythematosus in children |
| Q37545475 | Alterations of white matter structural networks in patients with non-neuropsychiatric systemic lupus erythematosus identified by probabilistic tractography and connectivity-based analyses |
| Q92307474 | Altered Amplitude of Low-Frequency Fluctuations in Inactive Patients with Nonneuropsychiatric Systemic Lupus Erythematosus |
| Q92509150 | Altered Olfactory Function in Patients with Systemic Lupus Erythematosus |
| Q48502994 | Altered white matter microstructure in lupus patients: a diffusion tensor imaging study |
| Q43786930 | Anti-DNA meets NMDA in neuropsychiatric lupus |
| Q64099017 | Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus |
| Q26996498 | Anti-NR2A/B Antibodies and Other Major Molecular Mechanisms in the Pathogenesis of Cognitive Dysfunction in Systemic Lupus Erythematosus |
| Q48210362 | Anti-SS-A (Ro) antibody is positively associated with steroid-induced psychiatric events in systemic lupus erythematosus patients |
| Q33608727 | Anti-alpha-internexin autoantibody from neuropsychiatric lupus induce cognitive damage via inhibiting axonal elongation and promote neuron apoptosis |
| Q81655941 | Anti-histones antibodies in systemic lupus erythematosus: prevalence and frequency in neuropsychiatric lupus |
| Q81128351 | Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates |
| Q34655140 | Anti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and clinical profile. |
| Q36011424 | Anti-ribosomal-phosphoprotein autoantibodies penetrate to neuronal cells via neuronal growth associated protein, affecting neuronal cells in vitro |
| Q34059923 | Antibodies against N-methyl-D-aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes |
| Q35740915 | Antibody induction of lupus-like neuropsychiatric manifestations |
| Q38841201 | Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria? |
| Q36337350 | Antiphospholipid-related chorea. |
| Q36927173 | Apolipoprotein E Gene Polymorphisms in Saudi Patients with Systemic Lupus Erythematosus |
| Q47877239 | Apolipoprotein E polymorphism in patients with neuropsychiatric SLE. |
| Q64094884 | Application of Plasma Exchange in Steroid-Responsive Encephalopathy |
| Q36787722 | Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus? |
| Q93088808 | Aseptic Meningitis and Depression: The Neuropsychiatric Manifestations of a Patient with Systemic Lupus Erythematosus |
| Q92627985 | Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance |
| Q36307418 | Assessment of cognitive function in systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis by computerized neuropsychological tests |
| Q47615899 | Assessment of the Hospital Anxiety and Depression Scale (HADS) performance for the diagnosis of anxiety in patients with systemic lupus erythematosus. |
| Q36784328 | Association between depression and vascular disease in systemic lupus erythematosus |
| Q34896821 | Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus |
| Q46951550 | Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus. |
| Q38815472 | Association of anti-triosephosphate isomerase antibodies with aseptic meningitis in patients with neuropsychiatric systemic lupus erythematosus. |
| Q34947235 | Association of antiphosphatidylserine/prothrombin antibodies with neuropsychiatric systemic lupus erythematosus |
| Q34374733 | Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus |
| Q36392326 | Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus |
| Q90520152 | Atmospheric Pollution Exposure Increases Disease Activity of Systemic Lupus Erythematosus |
| Q33664831 | Attention deficit and hyperactivity disorder scores are elevated and respond to N-acetylcysteine treatment in patients with systemic lupus erythematosus |
| Q42579446 | Attribution in the assessment of nervous system disease in SLE. |
| Q54246289 | Attribution of Neuropsychiatric Manifestations to Systemic Lupus Erythematosus. |
| Q64080290 | Autoantibodies against Neurologic Antigens in Nonneurologic Autoimmunity |
| Q36307423 | Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study |
| Q36332517 | Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus |
| Q90338344 | Autoantibodies associated with neuropsychiatric systemic lupus erythematosus: the quest for symptom-specific biomarkers |
| Q38222127 | Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review |
| Q37592934 | Autoantibodies to NR2A Peptide of the Glutamate/NMDA Receptor in Patients with Seizure Disorders in Neuropsychiatric Systemic Lupus Erythematosus |
| Q64110286 | Autoantibodies, elevated cytokines, and neurocognitive abnormalities in offspring of women with systemic lupus erythematosus: comparison with healthy controls |
| Q24805595 | Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies |
| Q35625134 | Autoantibody profiling on human proteome microarray for biomarker discovery in cerebrospinal fluid and sera of neuropsychiatric lupus |
| Q26785472 | Autoantigen Microarray for High-throughput Autoantibody Profiling in Systemic Lupus Erythematosus |
| Q36577209 | Autoimmune channelopathies |
| Q36310919 | Barriers and facilitators for mental healthcare in pediatric lupus and mixed connective tissue disease: a qualitative study of youth and parent perspectives |
| Q28082493 | Biomarkers for CNS involvement in pediatric lupus |
| Q33765429 | Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus |
| Q48485336 | Brain MRI in neuropsychiatric lupus: associations with the 1999 ACR case definitions |
| Q34478835 | Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus |
| Q89582476 | Brain Single Photon Emission Computed Tomography Scan (SPECT) and functional MRI in Systemic Lupus Erythematosus Patients with Cognitive Dysfunction: A Systematic Review |
| Q37613091 | Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus |
| Q47657635 | Brain magnetic resonance imaging, cerebrospinal fluid, and autoantibody profile in 118 patients with neuropsychiatric lupus. |
| Q35233633 | Brain metabolism and autoantibody titres predict functional impairment in systemic lupus erythematosus |
| Q37343283 | Brain morphometric changes associated with childhood-onset systemic lupus erythematosus and neurocognitive deficit |
| Q42137258 | Calcium/Calmodulin-Dependent Kinase IV Facilitates the Recruitment of Interleukin-17-Producing Cells to Target Organs Through the CCR6/CCL20 Axis in Th17 Cell-Driven Inflammatory Diseases. |
| Q36842422 | Cambridge Neuropsychological Test Automated Battery in assessment of cognitive parameters in patients with systemic lupus erythematosus in relation to autoantibody profile |
| Q58583826 | Carbamazepine-induced systemic lupus erythematosus: A case-based review |
| Q37019825 | Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus |
| Q30477512 | Case reports on two patients with episodic vertigo, fluctuating hearing loss and migraine responding to prophylactic drugs for migraine. Menière's disease or migraine-associated vertigo? |
| Q66679649 | Cataclysmically disseminating neurologic presentation in an immunosuppressed lupus patient: From the National Multiple Sclerosis Society Case Conference Proceedings |
| Q47261099 | Cavum Vergae, Liability, and Steroid Treatment: Manic Episode, Brain Imaging Findings, and Clinical Follow-up of a Systemic Lupus Erythematosus Case |
| Q39434326 | Cerebellar ataxia and obstructive hydrocephalus, rare neurologic presentations in patients with systemic lupus erythematosus. |
| Q33204474 | Cerebral vasculitis |
| Q47556201 | Cerebrovascular Events in Systemic Lupus Erythematosus |
| Q39043287 | Challenges of Diagnosing Cognitive Dysfunction With Neuropsychiatric Systemic Lupus Erythematosus in Childhood. |
| Q39389647 | Characterization of chronic arthritis in a multicenter study of 852 childhood-onset systemic lupus erythematosus patients |
| Q41858545 | Chorea as the first sign in a patient with elderly-onset systemic lupus erythematosus |
| Q38153171 | Chorea, a little-known manifestation in systemic lupus erythematosus: short literature review and four case reports |
| Q36766114 | Classification criteria for neuropsychiatric systemic lupus erythematosus: do they need a discussion? |
| Q33423763 | Clinical Characteristics of Cerebral Venous Sinus Thrombosis in Patients with Systemic Lupus Erythematosus: A Single-Centre Experience in China |
| Q26773164 | Clinical Features of Neuropsychiatric Syndromes in Systemic Lupus Erythematosus and Other Connective Tissue Diseases |
| Q43458251 | Clinical and laboratory profiles of systemic lupus erythematosus associated with Sjögren syndrome in China: a study of 542 patients. |
| Q47389486 | Clinical and serological associations of anti-ribosomal P0 protein antibodies in systemic lupus erythematosus |
| Q35743904 | Clinical and serological manifestations associated with interferon-α levels in childhood-onset systemic lupus erythematosus |
| Q42019937 | Clinical features and mortality in Chinese with lupus nephritis and neuropsychiatric lupus: A 124-patient study |
| Q64997838 | Clinical features and prognoses of acute transverse myelitis in patients with systemic lupus erythematosus. |
| Q92705193 | Clinical features of central nervous system infections and experience in differential diagnosis from neuropsychiatric lupus erythematosus in a cohort of 8491 patients with systemic lupus erythematosus |
| Q47226466 | Clinical features, outcome, and associated factors for posterior reversible encephalopathy in Thai patients with systemic lupus erythematosus: a case-control study. |
| Q50628077 | Clinicopathological features of multiple mononeuropathy associated with systemic lupus erythematosus: a multicenter study. |
| Q88094564 | Cognitive Impairment in Patients With Neuropsychiatric and Non-neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis |
| Q38034111 | Cognitive and emotional abnormalities in systemic lupus erythematosus: evidence for amygdala dysfunction |
| Q55305136 | Cognitive dysfunction improves in systemic lupus erythematosus: Results of a 10 years prospective study. |
| Q91951374 | Cognitive dysfunction in autoimmune rheumatic diseases |
| Q36434125 | Cognitive dysfunction in the patient with antiphospholipid antibodies: considerations for cause and treatment |
| Q37098605 | Cognitive impairment in persons with rheumatoid arthritis |
| Q37205229 | Comparison of the clinical manifestations, brain MRI and prognosis between neuroBeçhet's disease and neuropsychiatric lupus |
| Q94475991 | Comprehensive expression profile of long non-coding RNAs in Peripheral blood mononuclear cells from patients with neuropsychiatric systemic lupus erythematosus |
| Q36924181 | Concomitant Guillain Barre Syndrome and Transverse Myelitis as Initial Neuropsychiatric Manifestation in a Case of Lupus: A Diagnostic Quandary. |
| Q33633574 | Concomitant occurrence of cervical myelopathy, cerebral infarction, and peripheral neuropathy in systemic lupus erythematosus: a case report |
| Q42102814 | Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes |
| Q33547420 | Cortical thickness and subcortical gray matter reductions in neuropsychiatric systemic lupus erythematosus |
| Q38099203 | Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus |
| Q41813821 | Course of Neuropsychiatric Symptoms during Flares of Systemic Lupus Erythematosus (SLE). |
| Q33628713 | Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus |
| Q38578590 | Cytokines, neurophysiology, neuropsychology, and psychiatric symptoms |
| Q81387175 | Damage did not independently influence mortality in childhood systemic lupus erythematosus |
| Q36117913 | Decreased Coupling Between Functional Connectivity Density and Amplitude of Low Frequency Fluctuation in Non-Neuropsychiatric Systemic Lupus Erythematosus: a Resting-Stage Functional MRI Study |
| Q55234314 | Definition of NPSLE: Does the ACR Nomenclature Still Hold? |
| Q24678418 | Demyelination in rheumatic diseases |
| Q34217233 | Depression and anxiety and their association with healthcare utilization in pediatric lupus and mixed connective tissue disease patients: a cross-sectional study |
| Q34481224 | Depression as an initial feature of systemic lupus erythematosus? A case report |
| Q89099608 | Depression as the First Manifestation in a Young Girl With Juvenile Systemic Lupus Erythematosus |
| Q37323676 | Depressive and Anxiety Disorders in Systemic Lupus Erythematosus Patients without Major Neuropsychiatric Manifestations |
| Q36433143 | Depressive symptoms are associated with tumor necrosis factor alpha in systemic lupus erythematosus |
| Q41977234 | Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus |
| Q36142122 | Detection of cerebral embolic signals in patients with systemic lupus erythematosus |
| Q38686272 | Developing and Refining New Candidate Criteria for Systemic Lupus Erythematosus Classification: An International Collaboration |
| Q37149371 | Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. |
| Q38186995 | Diagnosis and management of neuropsychiatric SLE. |
| Q84814124 | Diagnosis of cognitive impairment in adult and pediatric SLE |
| Q33526071 | Diagnostic reliability of magnetic resonance imaging for central nervous system syndromes in systemic lupus erythematosus: a prospective cohort study |
| Q38617289 | Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus |
| Q33431990 | Differences in disease phenotype and severity in SLE across age groups |
| Q91673179 | Differential expression of antibodies to NMDA receptor in anti-NMDA receptor encephalitis and in neuropsychiatric systemic lupus erythematosus |
| Q38480540 | Diffuse alveolar hemorrhage in systemic lupus erythematosus: risk factors and clinical outcome: results from affiliated hospitals of Catholic University of Korea |
| Q34079262 | Diminished white matter integrity in patients with systemic lupus erythematosus |
| Q41501901 | Direct medical costs and their predictors in South Korean patients with systemic lupus erythematosus |
| Q34654491 | Discoveries in the pathophysiology of neuropsychiatric lupus erythematosus: consequences for therapy |
| Q47689292 | Discrepancy between subjective and objective measures of cognitive impairment in patients with rheumatoid arthritis. |
| Q54968810 | Disease activity, autoantibodies, and inflammatory molecules in serum and cerebrospinal fluid of patients with Systemic Lupus Erythematosus and Cognitive Dysfunction. |
| Q36633141 | Early cerebral volume reductions and their associations with reduced lupus disease activity in patients with newly-diagnosed systemic lupus erythematosus |
| Q64118295 | Editorial: Lupus and the Brain: Advances in Neuropsychiatric Systemic Lupus Erythematosus |
| Q43024897 | Effectiveness of olanzapine for systemic lupus erythematosus-related psychosis |
| Q41524233 | Effects of sustained i.c.v. infusion of lupus CSF and autoantibodies on behavioral phenotype and neuronal calcium signaling |
| Q35760171 | Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system |
| Q36721901 | Elevated cerebral blood flow and volume in systemic lupus measured by dynamic susceptibility contrast magnetic resonance imaging |
| Q41623712 | Elevated levels of soluble fractalkine and increased expression of CX3CR1 in neuropsychiatric systemic lupus erythematosus |
| Q58577181 | Elevation of serum anti-glucose-regulated protein 78 antibodies in neuropsychiatric systemic lupus erythematosus |
| Q73313602 | Enhanced interleukin-6 messenger RNA expression by neuronal cells in a patient with neuropsychiatric systemic lupus erythematosus |
| Q48382881 | Episodic memory impairment in systemic lupus erythematosus: involvement of thalamic structures |
| Q34746630 | Estrogen receptor alpha deficiency protects against development of cognitive impairment in murine lupus. |
| Q42695876 | Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus |
| Q31121775 | Evaluation of magnetic resonance imaging abnormalities in juvenile onset neuropsychiatric systemic lupus erythematosus |
| Q39822401 | Evaluation of white matter integrity in systemic lupus erythematosus by diffusion tensor magnetic resonance imaging: a study using tract-based spatial statistics. |
| Q89923880 | Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the 'Attikon' cohort |
| Q81484705 | Expression of S100B protein levels in serum and cerebrospinal fluid with different forms of neuropsychiatric systemic lupus erythematosus |
| Q53765631 | Eye movement and random number in NP lupus evaluation. |
| Q50785654 | Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case-control study from a single center. |
| Q47945037 | Fatigue in systemic lupus erythematosus : Association with disease activity, quality of life and psychosocial factors |
| Q57086559 | Focal transient lesions of the corpus callosum in systemic lupus erythematosus |
| Q59808939 | From Systemic Inflammation to Neuroinflammation: The Case of Neurolupus |
| Q91304142 | Functional connectivity changes in core resting state networks are associated with cognitive performance in systemic lupus erythematosus |
| Q92967092 | Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus |
| Q89804919 | Ganglionic Acetylcholine Receptor Antibodies and Autonomic Dysfunction in Autoimmune Rheumatic Diseases |
| Q37585137 | Gender and age influence on clinical and laboratory features in Chinese patients with systemic lupus erythematosus: 1,790 cases |
| Q84522715 | Genetic polymorphism of the growth arrest-specific 6 gene is associated with cutaneous vasculitis in Taiwanese patients with systemic lupus erythematosus |
| Q37220640 | Glial and axonal changes in systemic lupus erythematosus measured with diffusion of intracellular metabolites. |
| Q48180958 | Global Cognitive Impairment in Systemic Lupus Erythematosus Patients: A Structural MRI Study |
| Q38235715 | Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilep |
| Q33723529 | Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus |
| Q43556796 | Guillain-Barré syndrome as presenting feature in a patient with lupus nephritis, with complete resolution after cyclophosphamide treatment |
| Q42852286 | Guillain-Barré syndrome occurring synchronously with systemic lupus erythematosus as initial manifestation treated successfully with low-dose cyclophosphamide |
| Q26786620 | Guillian-Barre syndrome as the initial presentation of systemic lupus erythematosus--case report and review of literature |
| Q47578425 | High proportions of dementia among SLE patients: A big data analysis |
| Q37161550 | High-sensitivity C-reactive protein as an associate of clinical subsets and organ damage in systemic lupus erythematosus |
| Q35638477 | Hippocampal atrophy in systemic lupus erythematosus |
| Q35225108 | Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. |
| Q35656109 | IL-6 regulation of synaptic function in the CNS |
| Q90746894 | Identification of Levels of Serum Amyloid A and Apolipoprotein A1 in Serum Proteomic Analysis of Neuropsychiatric Systemic Lupus Erythematosus Patients |
| Q33865598 | Identification of three new autoantibodies associated with systemic lupus erythematosus using two proteomic approaches |
| Q37621292 | Identifying Differences in Risk Factors for Depression and Anxiety in Pediatric Chronic Disease: A Matched Cross-Sectional Study of Youth with Lupus/Mixed Connective Tissue Disease and Their Peers with Diabetes |
| Q37143756 | Idiopathic intracranial hypertension as an initial presentation of systemic lupus erythematosus |
| Q36472054 | Immunity and acquired alterations in cognition and emotion: lessons from SLE. |
| Q34270963 | Immunity and behavior: antibodies alter emotion |
| Q30834779 | Immunoserological changes in the cerebro-spinal fluid and serum in systemic lupus erythematosus patients with demyelinating syndrome and multiple sclerosis |
| Q36484399 | Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity |
| Q37434199 | Impact of immigration on the clinical expression of systemic lupus erythematosus: a comparative study of Hispanic patients residing in the USA and Mexico |
| Q33871723 | Impact of memory impairment on employment status in persons with systemic lupus erythematosus |
| Q52656278 | Impaired decision-making and functional neuronal network activity in systemic lupus erythematosus. |
| Q34592686 | Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients |
| Q47948566 | Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities |
| Q42393304 | Inflammatory profile in the cerebrospinal fluid of patients with central neuropsychiatric lupus, with and without associated factors |
| Q36313012 | Influence of ethnicity on childhood-onset systemic lupus erythematosus: results from a multiethnic multicenter Canadian cohort |
| Q48268721 | Insight into SLE-related migraine using brain single-photon-emission computed tomography |
| Q37032127 | Integrative neuroscience approach to neuropsychiatric lupus |
| Q40044431 | Interactions of antisera to different Chlamydia and Chlamydophila species with the ribosomal protein RPS27a correlate with impaired protein synthesis in a human choroid plexus papilloma cell line |
| Q38208255 | Interleukin 6 and cognitive dysfunction. |
| Q41952451 | International multicenter evaluation of autoantibodies to ribosomal P proteins |
| Q34947274 | Intracranial hypertension syndrome in systemic lupus erythematosus: clinical analysis and review of the literature |
| Q35185887 | Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus |
| Q42410293 | Intrathecal immunoglobulin production in patients with systemic lupus erythematosus with neuropsychiatric manifestations |
| Q48342620 | Intravenous thrombolysis in SLE-related stroke: a case report and literature review. |
| Q37627359 | Is frailty a relevant concept in SLE? |
| Q37468127 | Is it relevant to screen young women hospitalized in psychiatric department for neuropsychiatric systemic lupus erythematosus (NPSLE)?: A prospective study of 100 psychiatric inpatients |
| Q47896606 | Jaw Dystonia and Reversible Basal Ganglia Changes as an Initial Presentation of Systemic Lupus Erythematosus |
| Q36702788 | Juvenile systemic lupus erythematosus with primary neuropsychiatric presentation |
| Q60046879 | Laboratory and Neuroimaging Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: Where Do We Stand, Where To Go? |
| Q47172298 | Late diagnosis of systemic lupus erythematosus and antiphospholipid syndrome in an older woman with psychosis: a case report and review of the literature |
| Q97521856 | Leukoencephalopathy and cerebral edema as the presenting manifestations of SLE in an ANA-negative adolescent female: a case report and review of literature |
| Q30573314 | Libman-Sacks endocarditis and embolic cerebrovascular disease. |
| Q44360517 | Life-threatening extrarenal lupus in children despite improvement in serologic findings |
| Q33599086 | Linking complement and anti-dsDNA antibodies in the pathogenesis of systemic lupus erythematosus |
| Q40316468 | Lipid profile among girls with systemic lupus erythematosus |
| Q51823798 | Localization of cerebral functional deficits in patients with non-neuropsychiatric systemic lupus erythematosus. |
| Q46188376 | Longitudinally extensive transverse myelitis with anti-NMDA receptor antibodies during a systemic lupus erythematosus flare-up |
| Q38955448 | Lupus catatonia in a young girl who presented with fever and altered sensorium |
| Q48325919 | MR imaging findings suggestive of posterior reversible encephalopathy syndrome in adolescents with systemic lupus erythematosus |
| Q40406766 | MRI and 2D-CSI MR spectroscopy of the brain in the evaluation of patients with acute onset of neuropsychiatric systemic lupus erythematosus |
| Q36651573 | Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus. |
| Q26774815 | Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives |
| Q44436037 | Markers of acute neuropsychiatric systemic lupus erythematosus: a multidisciplinary evaluation |
| Q35156885 | Memantine in systemic lupus erythematosus: a randomized, double-blind placebo-controlled trial |
| Q43060467 | Microembolic signals in patients with systemic lupus erythematosus. |
| Q53165352 | Migraine is frequent in patients with systemic lupus erythematosus: A case-control study |
| Q37464019 | Molecular signatures in systemic lupus erythematosus: distinction between disease flare and infection |
| Q35797933 | Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study |
| Q38098473 | Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome |
| Q34753885 | Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus. |
| Q38635601 | Mycophenolate mofetil and deflazacort combination in neuropsychiatric lupus: a decade of experience from a tertiary care teaching hospital in southern India |
| Q37456167 | Myelitis in systemic lupus erythematosus: clinical features, immunological profile and magnetic resonance imaging of five cases |
| Q33862215 | Neurobrucellosis in systemic lupus erythematosus |
| Q34307491 | Neurocognitive deficits and neuroimaging abnormalities are prevalent in children with lupus: clinical and research experiences at a US pediatric institution |
| Q34213820 | Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage |
| Q35146121 | Neurocognitive impairment in childhood-onset systemic lupus erythematosus: measurement issues in diagnosis |
| Q34054877 | Neurocognitive impairment in children and adolescents with systemic lupus erythematosus |
| Q83594159 | Neurologic manifestations of systemic immunopathological diseases |
| Q34310715 | Neurologic manifestations of systemic lupus erythematosus in children and adults |
| Q55267080 | Neurological Disease in Lupus: Toward a Personalized Medicine Approach. |
| Q37663657 | Neurological Manifestations in Systemic Lupus Erythematosus: A Single Centre Study from North East India |
| Q38215698 | Neurology of rheumatologic disorders |
| Q92576080 | Neuronal BC RNA Transport Impairments Caused by Systemic Lupus Erythematosus Autoantibodies |
| Q55554942 | Neuropsychiatric Involvement in Juvenile-Onset Systemic Lupus Erythematosus. |
| Q93157178 | Neuropsychiatric Lupus Erythematosus: Future Directions and Challenges; a Systematic Review and Survey |
| Q30727936 | Neuropsychiatric Lupus, the Blood Brain Barrier, and the TWEAK/Fn14 Pathway |
| Q34459628 | Neuropsychiatric Symptoms in Lupus |
| Q73239513 | Neuropsychiatric Systemic Lupus Erythematosus |
| Q37632131 | Neuropsychiatric Systemic Lupus Erythematosus Involvement: Towards a Tailored Approach to Our Patients? |
| Q36902003 | Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway. |
| Q36440223 | Neuropsychiatric features of a cohort of patients with systemic lupus erythematosus |
| Q34749154 | Neuropsychiatric involvement in systemic lupus erythematosus |
| Q34250901 | Neuropsychiatric lupus |
| Q30480899 | Neuropsychiatric lupus and association with cerebrospinal fluid immunoglobulins: a pilot study. |
| Q27027588 | Neuropsychiatric lupus: a mosaic of clinical presentations |
| Q37800296 | Neuropsychiatric lupus: clinical challenges, brain-reactive autoantibodies and treatment strategies |
| Q91117776 | Neuropsychiatric lupus: new mechanistic insights and future treatment directions |
| Q51648992 | Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India. |
| Q47831929 | Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India |
| Q36749976 | Neuropsychiatric manifestations in patients with systemic lupus erythematosus: A study from Iran |
| Q37922765 | Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management |
| Q34075832 | Neuropsychiatric manifestations of systemic lupus erythematosus: Iranian experience |
| Q38831844 | Neuropsychiatric symptoms in systemic lupus erythematosus: impact on quality of life |
| Q59924786 | Neuropsychiatric systemic lupus erythematosus |
| Q42539014 | Neuropsychiatric systemic lupus erythematosus reconsidered |
| Q35204117 | Neuropsychiatric systemic lupus erythematosus: a diagnostic challenge |
| Q38247180 | Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers |
| Q33339985 | Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosis |
| Q36392300 | Neuropsychological patterns in systemic lupus erythematosus patients with depression |
| Q36821488 | New insights into central nervous system lupus: a clinical perspective |
| Q48229388 | New-onset psychiatric disorders after corticosteroid therapy in systemic lupus erythematosus: an observational case-series study |
| Q47136259 | Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study |
| Q26796871 | Non-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosus |
| Q51894626 | Obsessive-compulsive symptoms as a manifestation of neuropsychiatric systemic lupus erythematosus. |
| Q36265407 | Papulonodular mucinosis, Guillain-Barré syndrome and nephrotic syndrome in a patient with systemic lupus erythematosus: a case report |
| Q33574487 | Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations |
| Q44996535 | Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus |
| Q55387947 | Pediatric Systemic Lupus Erythematosus: Learning From Longer Follow Up to Adulthood. |
| Q37220152 | Peripheral and central mechanisms of fatigue in inflammatory and noninflammatory rheumatic diseases |
| Q36151124 | Peripheral neuropathies due to systemic lupus erythematosus in China |
| Q38036106 | Peripheral neuropathies in rheumatic disease--a guide to diagnosis |
| Q35861313 | Physical activity, obesity, and cognitive impairment among women with systemic lupus erythematosus |
| Q34343779 | Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program |
| Q37351240 | Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus |
| Q38156069 | Pragmatic approaches to therapy for systemic lupus erythematosus |
| Q84594208 | Predictors for neuropsychiatric development in Chinese adolescents with systemic lupus erythematosus |
| Q73251573 | Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus |
| Q47788785 | Prevalence and features of metabolic syndrome in childhood-onset systemic lupus erythematosus. |
| Q51069301 | Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. |
| Q34087831 | Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus |
| Q61914198 | Protocolo diagnóstico de la afectación neurológica central en conectivopatías y vasculitis |
| Q35226381 | Psychiatric disorders in patients with systemic lupus erythematosus: association of anxiety disorder with shorter disease duration |
| Q40414925 | Psychiatric manifestations in a patient after surgical management of aortic stenosis of systemic lupus erythematosus |
| Q57495680 | Psycho-rheumatic Integration in Systemic Lupus Erythematosus: An Insight into Antibodies Causing Neuropsychiatric Changes |
| Q58093032 | Psychosis in Systemic Lupus Erythematosus |
| Q34321259 | Psychosis in a young female – a diagnostic and therapeutic challenge |
| Q35993201 | Psychosis in patients with systemic lupus erythematosus |
| Q48301096 | Psychosis leading to the diagnosis of unrecognized systemic lupus erythematosus: a case report |
| Q36319615 | Quality of life in children with systemic lupus erythematosus |
| Q35636738 | Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus |
| Q35637257 | Raised serum S100B protein levels in neuropsychiatric lupus. |
| Q37638315 | Reduced Insular Glutamine and N-acetylaspartate in systemic lupus erythematosus: a single-voxel (1)H-MR spectroscopy study |
| Q34018666 | Regional brain metabolism in a murine systemic lupus erythematosus model. |
| Q36720077 | Relationship Between Clinical and Immunological Features with Magnetic Resonance Imaging Abnormalities in Female Patients with Neuropsychiatric Systemic Lupus Erythematosus |
| Q58557521 | Relationship between cerebral microbleeds and white matter MR hyperintensities in systemic lupus erythematosus: a retrospective observational study |
| Q81462541 | Relationship between clinical factors and neuropsychiatric manifestations in systemic lupus erythematosus |
| Q37205722 | Relationship between perceived cognitive dysfunction and objective neuropsychological performance in persons with rheumatoid arthritis |
| Q100533947 | Resting state network functional connectivity abnormalities in systemic lupus erythematosus: correlations with neuropsychiatric impairment |
| Q102379450 | Retinal and choroidal thickness changes in systemic lupus erythematosus patients: a longitudinal study |
| Q57464055 | Reversible Cognitive Dysfunction in Elderly-onset Systemic Lupus Erythematosus, Successfully Treated with Aggressive Immunosuppressive Therapy |
| Q48008176 | Reversible dementia in systemic lupus erythematosus without antiphospholipid antibodies or cerebral infarction |
| Q43806069 | Reversible parkinsonism in systemic lupus erythematosus |
| Q38374309 | Reviewing the recommendations for lupus in children |
| Q58755522 | Risk factors for damage in childhood-onset systemic lupus erythematosus in Asians: a case control study |
| Q34155285 | Risk of epilepsy in patients with systemic lupus erythematosus - a retrospective cohort study |
| Q40886149 | Role of IL-1β, IL-6, IL-8 and IFN-γ in pathogenesis of central nervous system neuropsychiatric systemic lupus erythematous |
| Q45736321 | Role of eye's sign in patients with neuropsychiatric disorders of systemic lupus erythematosus |
| Q37226689 | SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus |
| Q52673324 | SLE presenting as demyelinative autoimmune visual loss. |
| Q41864966 | SLE presenting with catatonia in an adolescent girl |
| Q24817163 | Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations |
| Q36307429 | Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study |
| Q31129756 | Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV). |
| Q35947538 | Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-D-Aspartate Receptor. |
| Q28212921 | Selective involvement of the amygdala in systemic lupus erythematosus |
| Q34061733 | Seroprevalence and specificity of NMO-IgG (anti-aquaporin 4 antibodies) in patients with neuropsychiatric systemic lupus erythematosus |
| Q33941483 | Serum S100B levels in patients with lupus erythematosus: preliminary observation |
| Q33374004 | Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis |
| Q35666611 | Serum interleukin-17 levels are associated with nephritis in childhood-onset systemic lupus erythematosus |
| Q42281246 | Serum protein pattern associated with organ damage and lupus nephritis in systemic lupus erythematosus revealed by PEA immunoassay |
| Q54936247 | Severe Maternal Morbidity Associated with Systemic Lupus Erythematosus Flare in the Second Trimester of Pregnancy. |
| Q42360078 | Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: an alternative to standard of care |
| Q84765443 | Severe systemic lupus erythematosus in emergency department: a retrospective single-center study from China |
| Q36307414 | Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study |
| Q86096678 | Significance of antibodies against the native ribosomal P protein complex and recombinant P0, P1, and P2 proteins in the diagnosis of Chinese patients with systemic lupus erythematosus |
| Q37588327 | Silent Burdens in Disease: Fatigue and Depression in SLE |
| Q64054170 | Simultaneous Oculomotor and Facial Nerve Palsies in a Patient with Systemic Lupus Erythematosus and Sjögren's Syndrome |
| Q36620497 | Skin damage occurs early in systemic lupus erythematosus and independently of disease duration in Brazilian patients |
| Q42955594 | Soluble fractalkine in the cerebrospinal fluid of patients with neuropsychiatric lupus |
| Q39202902 | Subclinical Pulmonary Hypertension in Childhood Systemic Lupus Erythematosus Associated with Minor Disease Manifestations |
| Q37358235 | Subclinical cerebrovascular cognitive function, and mood changes in patients with systemic lupus erythematosus |
| Q83774560 | Superoxide release in juvenile systemic lupus erythematosus |
| Q58779504 | Symptoms of systemic lupus erythematosus are diagnosed in leptin transgenic pigs |
| Q92557518 | Systemic Lupus Erythematosus Presenting as Optic Neuropathy: A Case Report |
| Q64088695 | Systemic Lupus Erythematosus With Isolated Psychiatric Symptoms and Antinuclear Antibody Detection in the Cerebrospinal Fluid |
| Q47610425 | Systemic autoimmune diseases complicated with hydrocephalus: pathogenesis and management. |
| Q55933861 | Systemic lupus erythematosus |
| Q73730202 | Systemic lupus erythematosus |
| Q79778268 | Systemic lupus erythematosus and Sjögren's syndrome: historical perspective and ongoing concerns |
| Q48700684 | Systemic lupus erythematosus and right leg weakness. |
| Q35937216 | Systemic lupus erythematosus associated with familial moyamoya disease |
| Q39423577 | Systemic lupus erythematosus in Egyptian children |
| Q78374010 | Systemic lupus erythematosus in childhood |
| Q35947491 | Systemic lupus erythematosus in children and adolescents |
| Q34034374 | Systemic lupus erythematosus in the elderly. |
| Q48371634 | Systemic lupus erythematosus manifested as drug-resistant mesial temporal lobe epilepsy |
| Q30966801 | Systemic lupus erythematosus presenting with recurrent psychiatric disturbances |
| Q89164953 | Systemic lupus erythematosus with Guillian-Barre syndrome: A case report and literature review |
| Q44474146 | Systemic lupus erythematosus with disease onset after age 65 |
| Q37930475 | Systemic lupus erythematosus, the brain, and anti-NR2 antibodies |
| Q51803434 | Systemic lupus erythematosus. |
| Q37722596 | TWEAK as a target for therapy in systemic lupus erythematosus. |
| Q58051934 | The Montreal Cognitive Assessment Test: A Useful Tool in Screening of Cognitive Impairment in Patients With Systemic Lupus Erythematosus |
| Q41684146 | The Role of Brain-Reactive Autoantibodies in Brain Pathology and Cognitive Impairment |
| Q55514340 | The association between systemic lupus erythematosus and dementia A meta-analysis. |
| Q34240032 | The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature |
| Q45868895 | The clinical impact of neuropsychiatric manifestations in early systemic lupus erythematosus |
| Q34913499 | The emerging link between autoimmune disorders and neuropsychiatric disease |
| Q36729344 | The histopathologic associates of neurometabolite abnormalities in fatal neuropsychiatric systemic lupus erythematosus |
| Q37552138 | The impact and implications of neuropsychiatric systemic lupus erythematosus in adolescents |
| Q87928075 | The incidence of and risk factors for developing atypical femoral fractures in Japan |
| Q47289398 | The introspection on the diagnosis and treatment process of a case of Guillain-Barré syndrome (GBS) attributed to systemic lupus erythematosus (SLE): A case report |
| Q37137840 | The relationship between cognitive function and physical function in rheumatoid arthritis |
| Q34681085 | The relationship between processing speed and working memory demand in systemic lupus erythematosus: Evidence from a visual n-back task |
| Q38889566 | The role of B cells and autoantibodies in neuropsychiatric lupus |
| Q52722816 | The role of septin 7 in physiology and pathological disease: A systematic review of current status. |
| Q37137299 | Time to neuropsychiatric damage occurrence in LUMINA (LXVI): a multi-ethnic lupus cohort |
| Q35569516 | Transient life-threatening cerebral edema in a patient with systemic lupus erythematosus |
| Q36015898 | Treatment of acute neuropsychiatric lupus with intravenous immunoglobulin (IVIG): a case report and review of the literature |
| Q44515995 | Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study |
| Q36014234 | Tumefactive demyelination associated with systemic lupus erythematosus. |
| Q53421838 | Tumor-like cerebral perivasculitis in a pediatric patient with systemic lupus erythematosus. |
| Q92332751 | Unique primed status of microglia under the systemic autoimmune condition of lupus-prone mice |
| Q27005906 | Unmet medical needs in systemic lupus erythematosus |
| Q37145894 | Unusual aetiology of isolated lower motor neuron facial palsy: systemic lupus erythematosus presenting with cranial nerve palsy and nephritis |
| Q37036848 | Using the Center for Epidemiologic Studies Depression Scale to screen for depression in systemic lupus erythematosus |
| Q36460419 | Validation of the Pediatric Automated Neuropsychological Assessment Metrics in childhood-onset systemic lupus erythematosus |
| Q36995068 | Validity of brief screening tools for cognitive impairment in rheumatoid arthritis and systemic lupus erythematosus |
| Q40181738 | Validity of the Italian algorithm for the attribution of neuropsychiatric events in systemic lupus erythematosus: a retrospective multicentre international diagnostic cohort study |
| Q38070123 | Valproate-induced hyperammonaemia superimposed upon severe neuropsychiatric lupus: a case report and review of the literature |
| Q33195490 | Value of MRI of the brain in patients with systemic lupus erythematosus and neurologic disturbance |
| Q36875118 | Vocal cords palsy in systemic lupus erythematosus patient: diagnostic and therapeutic difficulties |
| Q37158595 | White matter abnormalities and working memory impairment in systemic lupus erythematosus |
| Q34145793 | White matter correlates of neuropsychological dysfunction in systemic lupus erythematosus |
| Q77715095 | [Clinical and serological characteristics of systemic lupus erythematosus: 128 cases] |
| Q81753280 | [Diagnosis and therapy of neurological manifestations of inflammatory rheumatic diseases] |
| Q75310693 | [MRI of central nervous system in a series of 58 systemic lupus erythematosus (SLE) patients with or without overt neuropsychiatric manifestations] |
| Q73471002 | [Myelopathy revealing lupus. Two cases and review of the literature] |
| Q84299651 | [Neurological focus in a female patient with systemic lupus erythematosus] |
| Q52887081 | [Neurological manifestations in connective tissue disease]. |
| Q79346029 | [Parkinsonian syndrome during the systemic lupus erythematosus: a case report] |
| Q79783581 | [Peripheral neuropathy in systemic lupus erythematosus with epineural vasculitis and antiphospholipid antibodies] |
| Q83274218 | [Rituximab in treatment for neuroimmunological diseases] |
| Q94466051 | [Systemic lupus erythematosus presenting with a choreo-athetosic syndrome associated with antiphospholipid antibodies] |
| Q84600757 | [Systemic lupus erythematosus. Infrequent clinical aspects] |
| Q52913359 | [Systemic lupus erythematosus. Target criteria for treatment]. |
| Q84600028 | [Treatment of neuropsychiatric manifestations of systemic lupus erythematosus] |
| Q89977007 | mTOR-Related Cell-Clearing Systems in Epileptic Seizures, an Update |
Search more.